ReverbaLINK: A unique technology platform driving clinical trial participation to enhance success

Reverba (formerly Health Perspectives Group), a global patient engagement solutions organization for biopharmaceutical and other healthcare organizations, has changed the way companies engage with healthcare consumers from the early-stage drug discovery phase, through clinical development and ultimately commercialization. Reverba helps clients understand the value of an enhanced patient experience wherever those patient touchpoints occur. For more than 20 years, Reverba has incorporated compliance throughout its technology platforms and patient engagement solutions, maintaining SOC 2 Type II certification for the highest level of security.

Evolved from the merger of Health Advocacy Strategies, Patient Health Perspectives, and Health Perspectives Group, the company rebranded as Reverba in 2021. The company also created Health Stories Project, a wholly owned subsidiary of Reverba that is a social sharing community about personal health experiences, participation in clinical trials, and other activities. Earlier this year, the company announced the acquisition of Six Degrees Worldwide Inc., a leader in medical communications. The acquisition is poised to help Reverba, and its clients continue to bridge the gap between science and real-life patient experiences.

Reverba’s first-in-class engagement solutions have touched tens of thousands of people and helped them get the support they need and convey their point of view directly to the companies developing drugs and products for their care. Having worked on over 125 healthcare brands, 70+ of those being blockbuster brands, across 450 disease conditions (and 40 rare disease conditions), the companies that Reverba has guided to improve their programs have reached countless other patients directly or indirectly over the lifespan of the business.

The power of the patient voice is becoming a reality in today’s healthcare industry because Reverba has shaped the framework around what patient engagement can mean for both the biopharma industry and for patients themselves. Reverba leads this space intending to unite science with the patient perspective, revolutionizing how scientific information is communicated to and understood by diverse groups of patients all over the world, and making meaningful connections with the lives it aims to improve.